| Data show that glycogen synthase kinase 3 (GSK3) and proto-oncogene proteins B-raf (BRAF)/MAPK signaling converges to control microphthalmia-associated transcription factor MITF (MITF) nuclear export. | None |
| Studied use of B-Raf proto-oncogene serine/threonine kinase (BRAF) mutational analysis as a tumor marker in canine transitional cell carcinoma. | None |
| Ectopic introduction of SPRY4 recapitulated the growth arrest phenotype of dual BRAF(V600E)/NRAS(Q61) expression while SPRY4 depletion led to a partial rescue from oncogenic antagonism. | None |
| Analyses of the oncogenic BRAF(D594G) variant reveal a kinase-independent function of BRAF in activating MAPK signaling. | None |
| Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. | None |
| B-raf oncogene: activation by rearrangements and assignment to human chromosome 7. | None |
| Genomic organization and nucleotide sequence of the coding region of the chicken c-Rmil(B-raf-1) proto-oncogene. | None |
| Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf. | None |